Risk of anaphylaxis after vaccination in children and adults

Journal of Allergy and Clinical Immunology

Volumn 137, Issue 3, 2016, Pages 868-878

  McNeil, Michael M ^a   Weintraub, Eric S ^a   Duffy, Jonathan ^a   Sukumaran, Lakshmi ^a   Jacobsen, Steven J ^b   Klein, Nicola P ^b   Hambidge, Simon J ^c   Lee, Grace M ^d   Jackson, Lisa A ^e   Irving, Stephanie A ^f   King, Jennifer P ^g   Kharbanda, Elyse O ^h   Bednarczyk, Robert A ⁱ   Destefano, Frank ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b KAISER PERMANENTE   (United States)

^c KAISER PERMANENTE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e GROUP HEALTH RESEARCH INSTITUTE   (United States)

^f CENTER FOR HEALTH RESEARCH   (United States)

^g MARSHFIELD CLINIC   (United States)

^h HEALTHPARTNERS INSTITUTE   (United States)

ⁱ EMORY UNIVERSITY   (United States)

Author keywords

Anaphylaxis; immunization; vaccine safety

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; INACTIVATED VACCINE; INFLUENZA VACCINE; RABIES VACCINE; VARICELLA ZOSTER VACCINE; VACCINE;

ADULT; ANAPHYLAXIS; ARTICLE; ASTHMA; CHILD; FEMALE; HUMAN; ICD-9-CM; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION; YOUNG ADULT; ADOLESCENT; ADVERSE EFFECTS; AGED; RISK;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK; VACCINATION; VACCINES; YOUNG ADULT;

EID: 84964888967     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.07.048     Document Type: Article

References (48)

1. K.F. Austen Disease of immediate type hypersensitivity K.J. Isselbacher, E. Braunwald, J.D. Wilson, J.B. Martin, A.S. Fauci, D.L. Kasper, Harrison's principles of internal medicine 13th ed. 1994 McGraw-Hill New York 1630 1638
2. F.E. Simmons Anaphylaxis J Allergy Immunol 125 suppl 2010 S161 S181
3. P. Lieberman, R.A. Nicklas, J. Oppenheimer, S.F. Kemp, D.M. Lang, D.I. Bernstein, and et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update J Allergy Clin Immunol 126 2010 477 480 e1-e42
4. F.E. Simons, L.R. Ardusso, B. Bilo, Y.M. El-Gamal, D.K. Ledford, J. Ring, and et al. World Allergy Organization guidelines for the assessment and management of anaphylaxis J Allergy Clin Immunol 127 593 2011 e1 e22
5. Centers for Disease Control and Prevention General recommendations on immunization - recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 60 2011 1 64
6. J.M. Kelso, J.T. Li, R.A. Nicklas, J. Blessing-Moore, L. Cox, D.M. Lang, and et al. Adverse reactions to vaccines Ann Allergy Asthma Immunol 103 4 Suppl 2 2009 S1 S14
7. K. Stratton, A. Ford, E. Rusch, and E.W. Clayton Adverse effects of vaccines: evidence and causality. Institute of Medicine 2011 National Academies Press Washington (DC)
8. J.D. Grabenstein Clinical management of hypersensitivities to vaccine components Hospital Pharmacy 32 1997 77 87
9. J.T. Lear, and J.S. English Anaphylaxis after hepatitis B vaccination Lancet 345 1995 1249
10. J. Baggs, J. Gee, E. Lewis, G. Fowler, P. Benson, T. Lieu, and et al. The Vaccine Safety Datalink: a model for monitoring vaccine safety Pediatrics 127 suppl 2011 S45 S53
11. K. Bohlke, R.L. Davis, S.M. Marcy, M.M. Braun, F. DeStefano, S.B. Black, and et al. Risk of anaphylaxis after vaccination of children and adolescents Pediatrics 112 2003 815 820
12. J.U. Ruggeberg, M.S. Gold, J.M. Bayas, M.D. Blum, J. Bonhoeffer, S. Friedlander, and et al. Anaphylaxis: case definition and guidelines for data collection, analysis and presentation of immunization safety data Vaccine 25 2007 5675 5684
13. M.M. McNeil, J. Gee, E.S. Weintraub, E.A. Belongia, G.M. Lee, J.M. Glanz, and et al. The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety Vaccine 32 2014 5390 5398
14. K.J. Rothman, and J.D. Boice Jr. Epidemiologic analysis with a programmable calculator 1979 National Institutes of Health Bethesda (MD) 31 32 NIH publication no. 79-1649
15. L.A. Grohskopf, S.J. Olsen, L.Z. Sokolow, J.S. Bresee, N.J. Cox, K.R. Broder, and et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) - United States, 2014-15 influenza season MMWR Morb Mortal Wkly Rep 63 2014 691 697
16. H.A. Sampson, A. Muñoz-Furlong, S.A. Bock, C. Schmitt, R. Bass, B.A. Chowdhury, and et al. Symposium on the definition and management of anaphylaxis: summary report J Allergy Clin Immunol 115 2005 584 592
17. H.A. Sampson, A. Muñoz-Furlong, R.L. Campbell, N.F. Adkinson, S.A. Bock, A. Branum, and et al. Second symposium on the definition and management of anaphylaxis: summary report - second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium J Allergy Clin Immunol 117 2006 391 397
18. M. Erlewyn-Lajeunesse, L.P. Hunt, P.T. Heath, and A. Finn Anaphylaxis as an adverse event following immunization in the UK and Ireland Arch Dis Child 97 2012 487 490
19. J.M. Brotherton, M.S. Gold, A.S. Kemp, P.B. McIntyre, M.A. Burgess, S. Campbell-Lloyd, and et al. Anaphylaxis following quadrivalent human papillomavirus vaccination CMAJ 179 2008 525 533
20. I. Rouleau, G. De Serres, J.P. Drolet, D.M. Skowronski, M. Ouakki, A. Toth, and et al. Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine Vaccine 31 2013 5989 5996
21. F. Tavares, A. Delaigle, D. Slavin, V. Bauchau, L. Fries, and H. Siefert Anaphylaxis following H1N1 pandemic vaccines: safety data in perspective Vaccine 29 2011 6402 6407
22. C. Vellozzi, K.R. Broder, P. Haber, A. Guh, M. Nguyen, M. Cano, and et al. Adverse events following influenza A (H1N1) monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010 Vaccine 28 2010 7248 7255
23. C. Vellozzi, D.R. Burwen, A. Dobardzic, R. Ball, and P. Haber Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring Vaccine 27 2009 2114 2120
24. E. Jershow, R.Y. Lin, M.M. Scaperotti, and A.P. McGinn Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic association J Allergy Clin Immunol 134 2014 1318 1328
25. N. Sargant, M. Erlewyn-Lajeunesse, and J. Benger Does anaphylaxis masquerade as asthma in children? Emerg Med J 32 2015 83 84
26. M. Erlwyn-Lajeunesse, S. Dymond, I. Slade, H.L. Mansfield, R. Fish, O. Jones, and et al. Diagnostic utility of two case definitions for anaphylaxis: a comparison using retrospective case notes analysis in the UK Drug Saf 33 2010 57 64
27. P.L. Lieberman Anaphylaxis N. Adkinson, B. Bochner, W. Busse, S. Holgate, R. Lemanske, F. Simons, Middleton's allergy: principles and practice 7th ed. 2008 Mosby Philadelphia 1027 1050
28. A. Sheikh, J. Hippisley-Cox, J. Newton, and J. Fenty Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England J R Soc Med 101 2008 139 143
29. A. González-Peréz, Z. Aponte, C.F. Vidaurre, and L.A. Rodriguez Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review J Allergy Clin Immunol 125 2010 1098 1104
30. S. Clark, W. Wei, S.A. Rudders, and C.A. Camargo Jr. Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals J Allergy Clin Immunol 134 2014 1125 1130
31. W. Chen, M. Mempel, W. Schober, H. Behrendt, and J. Ring Gender difference, sex hormones, and immediate type hypersensitivity reactions Allergy 63 2008 1418 1427
32. W.W. Decker, R.L. Campbell, V. Manivannan, A. Luke, J.L. St Sauver, A. Weaver, and et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project J Allergy Clin Immunol 122 2008 1161 1165
33. I.F. Cook Sexual dimorphism of humoral immunity with human vaccines Vaccine 26 2008 3551 3555
34. I.F. Cook Sex differences in injection site reactions with human vaccines Hum Vaccin 5 2009 441 449
35. S.L. Klein, A. Jedlicka, and A. Pekosz The Xs and Y of immune responses to viral vaccines Lancet Infect Dis 10 2010 338 349
36. R.J. Engler, M.R. Nelson, M.M. Klote, M.J. VanRaden, C.Y. Haang, N.J. Cox, and et al. Half- vs full- dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses Arch Intern Med 156 2008 1546 1550
37. K.L. Nichol, K.L. Margolis, A. Lind, M. Murdoch, R. McFadden, M. Hauge, and et al. Side effects associated with influenza vaccination in healthy working adults: a randomized placebo-controlled trial Arch Intern Med 156 1996 1546 1550
38. M.K. Khalil, Y.Y. Al-Mazrou, Y.S. Al-Ghamdi, S. Tumsah, M. Al-Jeffri, and A. Meshkhas Effect of gender on reporting of MMR adverse events in Saudi Arabia East Mediter Health J 9 2003 152 158
39. C.M. Benjamin, G.C. Chew, and A.J. Silman Joint and limb symptoms in children after immunization with measles, mumps, and rubella vaccine BMJ 304 1992 1075 1078
40. L.M. Pennell, C.L. Galligan, and E.N. Fish Sex affects immunity J Autoimmun 38 2012 1075 1078
41. D. Verthelyi Sex hormones as immunomodulators in health and disease Int Immunopharmacol 1 2001 983 993
42. V. Hox, A. Desai, G. Bandara, A.M. Gilfillan, D.D. Metcalfe, and A. Olivera Estrogen increases the severity of anaphylaxis in female mice through enhanced endothelial nitric acid oxide synthetase expression and nitric oxide production J Allergy Clin Immunol 135 2015 729 736.e5
43. C. Iribarren, I.V. Tolstykh, M.K. Miller, and M.D. Eisner Asthma and the prospective risk of anaphylactic shock and other allergy diagnoses in a large integrated health care delivery system Ann Allergy Asthma Immunol 104 2010 371 377
44. F.E.R. Simons Pharmacologic treatment of anaphylaxis: can the evidence base be strengthened? Curr Opin Allergy Clin Immunol 10 2010 384 393
45. R.L. Campbell, A. Luke, A.L. Weaver, J.L. St Sauver, E.J. Bergstralh, J.T. Li, and et al. Prescriptions for self-injectable epinephrine and follow-up referral in emergency department patients presenting with anaphylaxis Ann Allergy Asthma Immunol 101 2008 631 636
46. R.L. Campbell, M.A. Park, M.A. Kieber, L. Sangil, and J.B. Hagan Outcomes of allergy/immunology follow-up after an emergency department evaluation for anaphylaxis J Allergy Clin Immunol Pract 3 2015 88 93
47. S.A. Rudders, S. Clark, W. Wei, and C.A. Camargo Longitudinal study of 954 patients with stinging insect anaphylaxis Ann Allergy Asthma Immunol 111 2013 199 204.e1
48. L.S. Dudley, M.I. Mansour, and M.A. Merlin Epinephrine for anaphylaxis: underutilized and unavailable West J Emerg Med 16 2015 385 387